Preliminary Evaluation of a RCMP to Predict Failure of Maxillomandibular Advancement Surgery for OSA
Preliminary Evaluation of a Remotely Controlled Mandibular Positioner to Predict Failure of Maxillomandibular Advancement Surgery for Obstructive Sleep Apnea
University of Michigan
20 participants
Aug 12, 2019
INTERVENTIONAL
Conditions
Summary
Maxillomandibular advancement (MMA) surgery, one of the most successful surgical procedures for the treatment of obstructive sleep apnea (OSA), is predominantly used to manage patients with moderate to severe OSA. However, limiting factors include incomplete response in some cases, unfavorable facial changes as a result of large advancements, and risk of malocclusion or malunion. This study will be done to determine predictors of success with MMA surgery in patients with moderate to severe OSA. Studies have already shown the value of a remote controlled mandibular positioner (RCMP) device to identify the correct level of therapeutic protrusion needed with oral appliance therapy. Moreover, some patients experience a dose dependent improvement in sleep parameters based on the degree of protrusion during the titration study. Use of RCMP as a means to identify potential candidates for MMA, may help customize treatment options for patients with OSA by providing predictive value.
Eligibility
Inclusion Criteria5
- AHI ≥ 15/hour
- years of age
- BMI 25-34.9
- Ideal operative candidate
- Unable or unwilling to use PAP
Exclusion Criteria9
- BMI ≥ 35
- younger than 30 or older than 65 years of age
- pregnancy
- Central sleep apnea (CSA) on baseline polysomnogram
- Chronic opioid use
- Active TMJ Disorders
- Inability to protrude the mandible beyond 5 mm
- Inability to follow-up after surgery
- Dental disorders including loose teeth or advanced periodontal disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
An overnight titration polysomnogram with gradual mandibular protrusion and assessment of polysomnographic parameters (i.e. AHI, oxygen saturation, etc.) at various magnitudes of protrusion.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03929549